Eli Lilly strikes optimistic tone on COVID-19 therapy after trial failure
Go back to Eli Lilly strikes optimistic tone on COVID-19 therapy after trial failure| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1160.08 +0.08 (0.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1160.00 | 52 Week High | $88.16 | |||
| Open | $1164.15 | 52 Week Low | $67.88 | |||
| Day High | $1187.83 | P/E | 268.54 | |||
| Day Low | $1158.00 | EPS | $4.32 | |||
| Volume | 2,446,352 | |||||
| Regeneron (NASDAQ: REGN) | Delayed: 852.03 +28.21 (3.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $823.82 | 52 Week High | $592.36 | |||
| Open | $826.24 | 52 Week Low | $325.35 | |||
| Day High | $854.49 | P/E | 223.63 | |||
| Day Low | $825.77 | EPS | $3.81 | |||
| Volume | 749,453 | |||||
